generations of glp 1 agonists Glucagon-like peptide-1 receptor and risk suicidality among patients with type 2 diabetes: active comparator, new user cohort study Dual and Triple Gut Peptide
Description
Combines GLP-1-mediated appetite suppression with glucagon-mediated energy expenditure and hepatic lipid metabolism
PMID: 33714600
lecture fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Lifescan, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche Diabetes Care, and Sanofi
Several studies have been carried out with the goal of deriving new class B GPCR targeting agents 8,9,10,11,12,13
It is a broad regulatory signal that touches virtually every branch of the immune system
A.CamisascaR
